Teresa Brophy Bair Kura Oncology, Inc. (KURA) insider trading activity

Teresa Brophy Bair is Chief Legal Officer of Kura Oncology, Inc.. Currently has a direct ownership of 107,948 shares of KURA, which is worth approximately $645,529. The most recent transaction as insider was on May 19, 2025, when has been sold 1,559 shares (Common Stock) at a price of $5.96 per share, resulting in proceeds of $9,291. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K

0% 3M change

56.49% 12M change

Total Value Held $645,529

Teresa Brophy Bair Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 19 2025	SELL Open market or private sale	$9,291 $5.96 p/Share	1,559 Reduced 1.42%	107,948 Common Stock
Jan 28 2025	SELL Open market or private sale	$57,301 $7.87 p/Share	7,281 Reduced 6.32%	107,948 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	46,250 Added 28.64%	115,229 Common Stock
May 20 2024	SELL Open market or private sale	$57,922 $22.15 p/Share	2,615 Reduced 3.65%	68,979 Common Stock
Jan 29 2024	SELL Open market or private sale	$36,543 $17.8 p/Share	2,053 Reduced 2.89%	68,979 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	46,250 Added 39.43%	71,032 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	23,125 Added 50.0%	23,125 Common Stock
Nov 17 2022	SELL Open market or private sale	$31,962 $15.22 p/Share	2,100 Reduced 100.0%	0 Common Stock

Also insider at

ATNX

Athenex, Inc. Healthcare

General Counsel, SVP Admin.

TBB